Bisphosphonate Treatment Fails to Improve Outcomes for Women With Chemoresistant Breast Cancer

MyHealthShare Uncategorized

See on Scoop.it – MyHealthShare Medical Reporter

SAN ANTONIO — Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer…

See on www.aacr.org

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out / Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Google+ photo

You are commenting using your Google+ account. ( Log Out / Change )

Cancel

Connecting to %s